University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer

Simple item page
dc.contributor.authorFerreiro-Iglesias, Aida
dc.contributor.authorMcKay, James D.
dc.contributor.authorBrenner, Nicole
dc.contributor.authorVirani, Shama
dc.contributor.authorLesseur, Corina
dc.contributor.authorGaborieau, Valerie
dc.contributor.authorNess, Andy R.
dc.contributor.authorHung, Rayjean J.
dc.contributor.authorLiu, Geoffrey
dc.contributor.authorDiergaarde, Brenda
dc.contributor.authorOlshan, Andrew F.
dc.contributor.authorHayes, Neil
dc.contributor.authorWeissler, Mark C.
dc.contributor.authorSchroeder, Lea
dc.contributor.authorBender, Noemi
dc.contributor.authorPawlita, Michael
dc.contributor.authorThomas, Steve
dc.contributor.authorPring, Miranda
dc.contributor.authorDudding, Tom
dc.contributor.authorKanterewicz, Beatriz
dc.contributor.authorFerris, Robert
dc.contributor.authorThomas, Sera
dc.contributor.authorBrhane, Yonathan
dc.contributor.authorDíez-Obrero, Virginia
dc.contributor.authorMilojevic, Maja
dc.contributor.authorSmith-Byrne, Karl
dc.contributor.authorMariosa, Daniela
dc.contributor.authorJohansson, Mattias J.
dc.contributor.authorHerrero, Rolando
dc.contributor.authorBoccia, Stefania
dc.contributor.authorCadoni, Gabriella
dc.contributor.authorLacko, Martin
dc.contributor.authorHolcátová, Ivana
dc.contributor.authorAhrens, Wolfgang
dc.contributor.authorLagiou, Pagona
dc.contributor.authorLagiou, Areti
dc.contributor.authorPolesel, Jerry
dc.contributor.authorSimonato, Lorenzo
dc.contributor.authorMerletti, Franco
dc.contributor.authorHealy, Claire M.
dc.contributor.authorHansen, Bo T.
dc.contributor.authorNygård, Mari
dc.contributor.authorConway, David I.
dc.contributor.authorWright, Sylvia
dc.contributor.authorMacfarlane, Tatiana V.
dc.contributor.authorRobinson, Max
dc.contributor.authorAlemany, Laia
dc.contributor.authorAgudo, Antonio
dc.contributor.authorZnaor, Ariana
dc.contributor.authorAmos, Christopher I.
dc.contributor.authorWaterboer, Tim
dc.contributor.authorBrennan, Paul
dc.contributor.institutionUniversity of Aberdeen.Dental Educationen
dc.date.accessioned2022-03-07T21:17:01Z
dc.date.available2022-03-07T21:17:01Z
dc.date.issued2021-10-12
dc.descriptionFunding Information: This study is part of an NIDCR funded project called VOYAGER (R01DE025712) with co-PIs Paul Brennan (IARC, Lyon), Brenda Diergaarde (University of Pittsburgh) and Neil Hayes (University of Tennessee Health Science Centre). Genotyping of cases and controls was performed at the Center for Inherited Disease Research (CIDR) and funded by the US National Institute of Dental and Craniofacial Research (NIDCR; 1X01HG007780-0). The work performed in MSH-PMH study was supported by The Canadian Cancer Society Research Institute (020214), Ontario Institute of Cancer, Canada Research Chair Award to R.J.H. and the Alan Brown Chair to G.L. and Lusi Wong Programs at the Princess Margaret Hospital Foundation. Coordination of the EPIC study is financially supported by the European Commission (DG SANCO) and the International Agency for Research on Cancer. The University of Pittsburgh head and neck cancer case–control study is supported by US National Institutes of Health grants P50CA097190 and P30CA047904. The Alcohol-Related Cancers and Genetic Susceptibility Study in Europe (ARCAGE) was funded by the European Commission’s fifth framework program (QLK1-2001-00182), the Italian Association for Cancer Research, Compagnia di San Paolo/FIRMS, Region Piemonte and Padova University (CPDA057222). The Carolina Head and Neck Cancer Study (CHANCE) was supported by the National Cancer Institute (R01CA90731). This publication presents data from the Head and Neck 5000 study. The study was a component of independent research funded by the National Institute for Health Research (NIHR) under its Program Grants for Applied Research scheme (RP-PG-0707-10034). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Core funding was also provided through awards from Above and Beyond, University Hospitals Bristol Research Capability Funding and the NIHR Senior Investigator award to Professor Andy Ness. Human papillomavirus (HPV) serology was supported by a Cancer Research UK Programme Grant, the Integrative Cancer Epidemiology Programme (grant number: C18281/A19169). This study is supported by the US National Institute of Dental and Craniofacial Research (R01DE025712 to P.B., B.D., and N.H.). The IARC Oral Cancer Multicenter study was funded by grant S06 96 202489 05F02 from Europe against Cancer; grants FIS 97/0024, FIS 97/0662 and BAE 01/5013 from Fondo de Investigaciones Sanitarias, Spain; the UICC Yamagiwa-Yoshida Memorial International Cancer Study; the National Cancer Institute of Canada; Associazione Italiana per la Ricerca sul Cancro; and the Pan-American Health Organization. The IARC Central Europe study was supported by the European Commission’s INCO-COPERNICUS Program (IC15-CT98-0332), US NIH/National Cancer Institute grant CA92039 and World Cancer Research Foundation grant WCRF 99A28. The Rome Study was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) awards IG 2011 10491 and IG 2013 14220 to S.B. and by Fondazione Veronesi to S.B. This publication presents data that contributes to the HEADSpAcE study supported by the European Union Horizon 2020 (grant no 825771).en
dc.description.statusPeer revieweden
dc.format.extent11
dc.format.extent1634544
dc.identifier214207146
dc.identifier2366e501-d917-4625-908e-3691a1c130e8
dc.identifier85117223831
dc.identifier34642315
dc.identifier.citationFerreiro-Iglesias, A, McKay, J D, Brenner, N, Virani, S, Lesseur, C, Gaborieau, V, Ness, A R, Hung, R J, Liu, G, Diergaarde, B, Olshan, A F, Hayes, N, Weissler, M C, Schroeder, L, Bender, N, Pawlita, M, Thomas, S, Pring, M, Dudding, T, Kanterewicz, B, Ferris, R, Thomas, S, Brhane, Y, Díez-Obrero, V, Milojevic, M, Smith-Byrne, K, Mariosa, D, Johansson, M J, Herrero, R, Boccia, S, Cadoni, G, Lacko, M, Holcátová, I, Ahrens, W, Lagiou, P, Lagiou, A, Polesel, J, Simonato, L, Merletti, F, Healy, C M, Hansen, B T, Nygård, M, Conway, D I, Wright, S, Macfarlane, T V, Robinson, M, Alemany, L, Agudo, A, Znaor, A, Amos, C I, Waterboer, T & Brennan, P 2021, 'Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer', Nature Communications, vol. 12, no. 1, 5945. https://doi.org/10.1038/s41467-021-26151-9en
dc.identifier.doi10.1038/s41467-021-26151-9
dc.identifier.iss1en
dc.identifier.issn2041-1723
dc.identifier.urihttps://hdl.handle.net/2164/18174
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85117223831&partnerID=8YFLogxKen
dc.identifier.vol12en
dc.language.isoeng
dc.relation.ispartofNature Communicationsen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subjectRK Dentistryen
dc.subjectGeneral Chemistryen
dc.subjectGeneral Biochemistry,Genetics and Molecular Biologyen
dc.subjectGeneral Physics and Astronomyen
dc.subjectEuropean Commissionen
dc.subjectIC15-CT98-0332en
dc.subject825771en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectRP-PG-0707-10034en
dc.subjectCancer Research UKen
dc.subjectC18281/A19169en
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.subject.lccRKen
dc.titleGermline determinants of humoral immune response to HPV-16 protect against oropharyngeal canceren
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ferrero_iglesias_Germline_determinants_of_VOR.pdf
Size:
1.56 MB
Format:
Adobe Portable Document Format
Download

Collections

All research